APA (7th ed.) Citation

DaSilva, N. A., Barlock, B. J., Guha, P., Ghosh, C. C., Trebino, C. E., Camberg, J. L., . . . Rowley, D. C. (2021). Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets. Cell death discovery, 7(1), 232-10. https://doi.org/10.1038/s41420-021-00621-x

Chicago Style (17th ed.) Citation

DaSilva, Nicholas A., Benjamin J. Barlock, Prajna Guha, Chandra C. Ghosh, Catherine E. Trebino, Jodi L. Camberg, Steven C. Katz, and David C. Rowley. "Proteomic Signatures of Myeloid Derived Suppressor Cells from Liver and Lung Metastases Reveal Functional Divergence and Potential Therapeutic Targets." Cell Death Discovery 7, no. 1 (2021): 232-10. https://doi.org/10.1038/s41420-021-00621-x.

MLA (9th ed.) Citation

DaSilva, Nicholas A., et al. "Proteomic Signatures of Myeloid Derived Suppressor Cells from Liver and Lung Metastases Reveal Functional Divergence and Potential Therapeutic Targets." Cell Death Discovery, vol. 7, no. 1, 2021, pp. 232-10, https://doi.org/10.1038/s41420-021-00621-x.